Sponsors (17)
The bill expands naloxone access, education, and stigma-reduction efforts to save lives and increase community readiness for overdoses, but it requires public resources, may face local resistance, and does not substitute for broader investment in addiction treatment and prevention.
People at risk of opioid overdose, their families, bystanders, and first responders will have greater access to naloxone and related training, increasing the chance of timely overdose reversal and reducing deaths and long-term brain injury.
Lowering barriers (including cost) and encouraging distribution by governments and organizations will expand naloxone availability in communities, making lifesaving doses more widely reachable.
Official recognition of National Naloxone Awareness Day and public education campaigns can reduce stigma around overdose prevention and encourage more people to obtain and carry naloxone.
Expanding access and awareness initiatives may require new government spending or subsidies, increasing costs for taxpayers and straining state or local budgets if funding is provided.
Emphasizing naloxone access alone does not treat opioid use disorder; without parallel investments in prevention, treatment, and recovery services, the measure may not reduce overall addiction rates or long-term harms.
Public distribution and awareness efforts could prompt political or community pushback in some areas, creating implementation challenges or uneven rollout across states and localities.
Based on analysis of 2 sections of legislative text.
Expresses findings on the opioid/fentanyl crisis, affirms naloxone's safety and OTC availability, urges education, stigma reduction, barrier identification (including cost), and recognizes National Naloxone Awareness Day.
Official title: Designating June 6, 2025, as National Naloxone Awareness Day.
Introduced June 10, 2025 by Richard Lynn Scott · Last progress June 10, 2025
Recognizes the severity of the opioid and fentanyl overdose crisis, notes federal findings on overdose deaths and fentanyl seizures, affirms that naloxone is safe and effective and was authorized for OTC sale, and calls for public education, stigma reduction, identification of barriers (including cost) to naloxone access and distribution, and designation of a National Naloxone Awareness Day to support those aims. The measure is a nonbinding expression of findings and intent focused on awareness and reducing barriers to life-saving naloxone.